MBC Alliance Publishes Third Article in our Epidemiology Series

New Study Shows a Decline in the Incidence of Recurrent Metastatic Breast Cancer Over Time
but no Improvement in Survival

New York, NY (February 1, 2019) A retrospective analysis –  reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom (11.6%) were later diagnosed with recurrent metastatic breast cancer (rMBC). The authors found a significant decline in rMBC over time, but no increase in survival. Survival after an rMBC diagnosis decreased over time, from 23% in the years between 1990 and 1998, to 21% between 1999 and 2004, and to 13% between 2005 and 2011.

Welcome to the Precision Medicine^* Revolution

*PRECISION MEDICINE is a form of medicine that uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat disease. In cancer, precision medicine uses specific information about a person’s tumor to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. Examples of precision medicine include using targeted therapies to treat specific types of cancer cell, such as HER2-positive breast cancer cells, or using tumor marker testing to help diagnose cancer.
Also called personalized medicine.

LEARN MORE

UPDATE!
Expanded Metastatic Breast Cancer Trial Search

We are excited to present the updated Metastatic Breast Cancer Trial Search, the first-ever clinical trial
search engine designed specifically for people with Metastatic Breast Cancer.

Click on the button below to enter your health information
and find trials that are right for you:

PLUS – Introducing Metastatic Trial Talk

A new companion portal that provides patients with carefully selected
news and features about metastatic breast cancer research.

MBC Alliance Clinical Trials Education Initiative

VISITto raise awareness of metastatic breast cancer!